(19)
(11) EP 1 094 844 A1

(12)

(43) Date of publication:
02.05.2001 Bulletin 2001/18

(21) Application number: 99933739.7

(22) Date of filing: 08.07.1999
(51) International Patent Classification (IPC)7A61K 48/00
(86) International application number:
PCT/US9915/329
(87) International publication number:
WO 0002/591 (20.01.2000 Gazette 2000/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.07.1998 US 112655

(71) Applicant: MERCK & CO., INC.
Rahway, New Jersey 07065 (US)

(72) Inventors:
  • VOLKIN, David, B.
    Rahway, NJ 07065 (US)
  • EVANS, Robert, K.
    Rahway, NJ 07065 (US)
  • ULMER, Jeffrey, B.
    Rahway, NJ 07065 (US)
  • CAULFIELD, Michael, J.
    Rahway, NJ 07065 (US)

(74) Representative: Thompson, John Dr. et al
Merck & Co., Inc.European Patent DepartmentTerlings ParkEastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) POLYNUCLEOTIDE VACCINE FORMULATIONS